EP3959235
Rítúxímab-þolnir blendings mótefnavakaviðtakar og notkun á þeim
Status:
EP einkaleyfi í gildi á ÍslandiEP appl. date:
24.4.2020EP published:
26.7.2023EP application number:
20728258.3
EP translation filed:
9.10.2023Grant published:
15.11.2023EPO information:
European Patent Register
Max expiry date:
23.4.2040Expiry date:
23.4.2026Next due date:
30.4.2026
Title in English:
RITUXIMAB-RESISTANT CHIMERIC ANTIGEN RECEPTORS AND USES THEREOFLanguage of the patent:
English
Timeline
Today
24.4.2020EP application
26.7.2023EP Publication
9.10.2023Translation submitted
15.11.2023Registration published
23.4.2026Expires
Owner
Name:
Allogene Therapeutics, Inc.Address:
210 E. Grand Avenue, South San Francisco, CA 94080, US
Inventor
Name:
PERTEL, Thomas CharlesAddress:
South San Francisco, California 94080, US
Name:
SASU, Barbra JohnsonAddress:
South San Francisco, California 94080, US
Name:
LEONARD, Mark W.Address:
South San Francisco, California 94080, US
Agent
Name:
Árnason Faktor ehf.Address:
Guðríðarstíg 2-4, 113, Reykjavík,
Priority
Number:
201962839455 PDate:
26.4.2019Country:
US
Number:
202063005041 PDate:
3.4.2020Country:
US
Classification
Categories:
C07K 14/725, A61K 31/505
Annual fees
Number
Paid
Expires
Payer
Number: 5
Paid: 7.3.2024
Expires: 23.4.2025
Payer: Árnason Faktor ehf.
Number: 6
Paid: 11.2.2025
Expires: 23.4.2026
Payer: Árnason Faktor ehf.